ARTICLE | Company News
SRI International autoimmune news
July 16, 2012 7:00 AM UTC
The U.S. Department of Defense awarded SRI a one-year grant to develop an oral inhibitor of microRNA-326 (miR-326) to treat multiple sclerosis (MS). SRI said the product is in the early stage of deve...